European Investor
27 Oct 2026, 16:03
HCA Healthcare Falls 4.6% as Payer Mix Pressure and Lower Net Income Offset Volume Growth
HCA Healthcare (NYSE: HCA) shares fell about 4.6% after the company reported third-quarter 2026 revenue growth and higher adjusted EPS, but also a decline in net income and a significant hit from a less favorable payer mix.
Revenue increased 3.6% year over year to $19.85 billion, while adjusted EBITDA rose 1.2% to $3.92 billion. Diluted EPS increased 4.5% to $7.27, and adjusted EPS rose 3.7% to $7.22.
Patient volumes remained healthy. Same-facility admissions increased 2.7%, equivalent admissions rose 3.0%, and emergency room visits climbed 5.1%. However, inpatient surgeries declined 1.4% and outpatient surgeries fell 3.7%.
The biggest concern was payer mix. HCA said an increase in uninsured patients, primarily from people losing health insurance exchange coverage, reduced pretax income by approximately $400 million during the quarter. Net income fell 3.9% to $1.58 billion despite higher revenue.
Management said full-year results are now expected to land in the upper half of its previously issued 2026 guidance ranges, supported by improving volume trends, better cost performance and higher Medicaid supplemental payment benefits.
The 4.6% decline appears to reflect investor concern over the $400 million payer-mix headwind and pressure from federal healthcare policy changes, which overshadowed solid admission growth and a relatively constructive full-year outlook.
HCA Healthcare (NYSE: HCA) shares fell about 4.6% after the company reported third-quarter 2026 revenue growth and higher adjusted EPS, but also a decline in net income and a significant hit from a less favorable payer mix.
Revenue increased 3.6% year over year to $19.85 billion, while adjusted EBITDA rose 1.2% to $3.92 billion. Diluted EPS increased 4.5% to $7.27, and adjusted EPS rose 3.7% to $7.22.
Patient volumes remained healthy. Same-facility admissions increased 2.7%, equivalent admissions rose 3.0%, and emergency room visits climbed 5.1%. However, inpatient surgeries declined 1.4% and outpatient surgeries fell 3.7%.
The biggest concern was payer mix. HCA said an increase in uninsured patients, primarily from people losing health insurance exchange coverage, reduced pretax income by approximately $400 million during the quarter. Net income fell 3.9% to $1.58 billion despite higher revenue.
Management said full-year results are now expected to land in the upper half of its previously issued 2026 guidance ranges, supported by improving volume trends, better cost performance and higher Medicaid supplemental payment benefits.
The 4.6% decline appears to reflect investor concern over the $400 million payer-mix headwind and pressure from federal healthcare policy changes, which overshadowed solid admission growth and a relatively constructive full-year outlook.
